Annals of Clinical Microbiology and Antimicrobials
Overview
The Annals of Clinical Microbiology and Antimicrobials is a peer-reviewed journal that focuses on the latest research and advancements in the field of clinical microbiology and antimicrobial agents. It covers a wide range of topics including diagnostics, epidemiology, treatment strategies, and resistance mechanisms. The journal serves as a valuable resource for healthcare professionals, researchers, and scientists working towards combating infectious diseases and improving patient care.
Details
Details
Abbr.
Ann Clin Microbiol Antimicrob
Publisher
Biomed Central
Start
1900s
End
Continuing
e-ISSN
1476-0711
Country
United Kingdom
Language
English
Specialties
Microbiology
Infectious Diseases
Infectious Diseases
Metrics
Metrics
h-index / Ranks: 5130
70
SJR / Ranks: 2866
1190
CiteScore / Ranks: 1874
8.80
JIF / Ranks: 1231
5.7
Recent Articles
1.
Genestet C, Bourg C, Hodille E, Bahuaud O, Ader F, Goutelle S, et al.
Ann Clin Microbiol Antimicrob
. 2025 Feb;
24(1):16.
PMID: 40022145
Objectives: Rifamycin agents (rifampicin (RIF), rifapentine (RFP), rifabutin (RFB)) are the cornerstone of tuberculosis (TB) therapy. Rifamycins are metabolized into 25-deacetyl-metabolites, which have been described has active and may contribute...
2.
Zanaty A, Dishisha T, El-Sayed-Ahmed M, Abdel-Fattah M, Ahmed K, Abdelkader K
Ann Clin Microbiol Antimicrob
. 2025 Feb;
24(1):17.
PMID: 40022070
Background: The dissemination of multi-drug-resistant bacteria, particularly Methicillin-resistant Staphylococcus aureus (MRSA), necessitates exploring new alternatives for their control. Bacteriophages are promising antibiotic alternatives with unique features. Here, we have performed...
3.
Andemichael Y, Habtetsion E, Gulbet H, Eman M, Achila O, Mengistu S, et al.
Ann Clin Microbiol Antimicrob
. 2025 Feb;
24(1):15.
PMID: 39984936
Background: An important knowledge gap exists on the epidemiology of blood stream infections (BSIs) in low-middle-income countries (LMICs). In this retrospective analysis, we evaluated the etiology, antimicrobial resistance (AMR) and...
4.
Yuan J, Ma L, Du J, Sun H, Li S, Zhou G, et al.
Ann Clin Microbiol Antimicrob
. 2025 Feb;
24(1):13.
PMID: 39962548
Metagenomic next-generation sequencing (mNGS) has greatly improved our understanding of pathogens in infectious diseases such as pulmonary tuberculosis (PTB). However, high human DNA background (> 95%) impedes the detection sensitivity...
5.
Dohal M, Wetzstein N, Hromadkova M, Masiarova S, Rasmussen E, Kunc P, et al.
Ann Clin Microbiol Antimicrob
. 2025 Feb;
24(1):14.
PMID: 39962513
Objectives: While the reported incidence of non-tuberculous mycobacterial (NTM) infections is increasing, the true prevalence remains uncertain due to limitations in diagnostics and surveillance. The emergence of rare and novel...
6.
Ain N, Elton L, Sadouki Z, McHugh T, Riaz S
Ann Clin Microbiol Antimicrob
. 2025 Feb;
24(1):12.
PMID: 39923059
Background: Carbapenemase-producing Enterobacterales pose a serious clinical threat, particularly in high-burden settings of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae (CREK), where rapid detection tools are essential to aid patient management....
7.
Kalu M, Jorth P, Wong-Beringer A
Ann Clin Microbiol Antimicrob
. 2025 Feb;
24(1):11.
PMID: 39920666
Background: Recurrent urinary tract infections (rUTIs) occur in over 20% of patients, with postmenopausal women (over 50 years old) carrying the highest risk for recurrence compared to younger women. Virulence...
8.
Vignaud E, Goutelle S, Genestet C, Guitton J, Cohen S, Bourg C, et al.
Ann Clin Microbiol Antimicrob
. 2025 Jan;
24(1):10.
PMID: 39885508
Background: Mycobacterium abscessus (MABS) causes difficult-to-treat pulmonary and extra-pulmonary infections. A combination therapy comprising amikacin, cefoxitin, and a macrolide agent is recommended, but its antimicrobial activity and clinical efficacy is...
9.
Feizi H, Kafil H, Plotnikov A, Kataev V, Balkin A, Filonchikova E, et al.
Ann Clin Microbiol Antimicrob
. 2025 Jan;
24(1):9.
PMID: 39881353
Background: Highly frequent colorectal cancer (CRC) is predicted to have 3.2 million novel cases by 2040. Tumor microenvironment (TME) bacteriome and metabolites are proposed to be involved in CRC development....
10.
Vedani T, Pot M, Garrigos T, Sababadichetty L, Daniel M, Wilkinson D, et al.
Ann Clin Microbiol Antimicrob
. 2025 Jan;
24(1):8.
PMID: 39881330
Aim: Located in the Southwest Indian Ocean area (SIOA), the two French overseas territories (FOTs) of Reunion and Mayotte islands are heavily impacted by antimicrobial resistance. The aim of this...